Treatment of Metastatic Melanoma with a Combination of Immunotherapies and Molecularly Targeted Therapies

Treatment of Metastatic Melanoma with a Combination of Immunotherapies and Molecularly Targeted Therapies

Melanoma possesses invasive metastatic growth patterns and is one of the most aggressive types of skin cancer. In 2021, it is estimated that 7180 deaths were attributed to melanoma in the United States alone. Once melanoma metastasizes, traditional therapies are no longer effective. Instead, immunot...

Full description

Bibliographic Details
Main Authors: Taylor Rager, Adam Eckburg, Meet Patel, Rong Qiu, Shahina Gantiwala, Katrina Dovalovsky, Kelly Fan, Katie Lam, Claire Roesler, Aayush Rastogi, Shruti Gautam, Namrata Dube, Bridget Morgan, S M Nasifuzzaman, Dhruv Ramaswami, Varun Gnanasekar, Jeffrey Smith, Aftab Merchant, Neelu Puri
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Cancers
Subjects:
molecularly targeted therapies
immunotherapies
melanoma
clinical trials
drug resistance
mutations
Online Access:https://www.mdpi.com/2072-6694/14/15/3779

Internet

https://www.mdpi.com/2072-6694/14/15/3779

Similar Items